Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
Clinical trial NCT05148871 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05148871
- Sponsor
- Vaxine Pty Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-02-23
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.